Concepedia

Long-term flecainide therapy in type 3 long QT syndrome

Ehud Chorin, Rivki Taub, Nir Flint, Sami Viskin, Jesaia Benhorin

EP Europace · 2017 · 34 citations · 23 references

DOIFull text

Open access

Abstract

These data suggest that long-term flecainide therapy is relatively safe and effective among LQT3 patients who carry the D1790G SCN5A mutation.

References

23

Genotype-Phenotype Correlation in the Long-QT Syndrome

Peter J. Schwartz, Silvia G. Priori, Carla Spazzolini et al. · Circulation · 2001 · 1.7K citations

Molecular mechanism for an inherited cardiac arrhythmia

Paul B. Bennett, Kazuto Yazawa, Naomasa Makita et al. · Nature · 1995 · 967 citations

, , +6

Long QT Syndrome Patients With Mutations of the <i>SCN5A</i> and <i>HERG</i> Genes Have Differential Responses to Na <sup>+</sup> Channel Blockade and to Increases in Heart Rate

Peter J. Schwartz, Silvia G. Priori, Emanuela H. Locati et al. · Circulation · 1995 · 812 citations

Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers

Silvia G. Priori · JAMA · 2004 · 596 citations

Modulating effects of age and gender on the clinical course of long QT syndrome by genotype

Wojciech Zaręba, Arthur J. Moss, Emanuela H. Locati et al. · Journal of the American College of Cardiology · 2003 · 278 citations

, , +6